My main areas of interest are bone marrow transplantation patients and rare diseases, particularly how we can improve outcomes through new drugs and therapies. Another related research interest is improving and standardizing treatment guidelines and protocols for blood disorders.
Hematologist Minakshi Taparia graduated from the Topiwala National Medical College, Mumbai University in Mumbai, India. She subsequently completed training in clinical and laboratory hematology in Australia and a clinical and laboratory hematology fellowship in the UK. She also has specialized training in bone marrow transplantation. She joined the Division of Hematology in 2006 and was promoted to clinical associate professor in 2016.
Leadership and Collaborations:
Dr. Taparia is a member of the Erdheim-Chester Disease Alliance and Histiocytic disorders. She was a member of the Residency Training Program for Hematology.
Dr. Taparia has an interest in clinical teaching, is actively involved in teaching activities and has mentored hematology fellows in the past.
Dr. Taparia has been a member on several clinical research teams running clinical trials to look at drug effectiveness in treating disorders including acute myeloid leukemia. She is co-author of several articles published in such journals as Cytotherapy, Leukemia Research and Clin Transplant.
Dr. Taparia is a staff hematologist at the University of Alberta Hospital and the Cross Cancer Institute in Edmonton. At the Cross, she works with the Bone Marrow Transplantation Clinic and in a second clinic specializing in rare diseases such as Cutaneous T cell lymphomas (CTCL), Langerhans cell histiocytosis and mastocytosis. She is also doing a joint clinic with Dermatology for seeing patients with CTCL, this helps provide the best treatment strategies for these rare diseases in a better fashion. Her other area of interest is Myeloproliferative diseases. She is also part of both institutions’ Alberta Blood and Marrow Transplant Program. Dr. Taparia has led or been involved with developing treatment guidelines and protocols for several blood disorders including acute promyelocytic leukemia and post-transplant lymphoproliferative disorder.